缺25-基维生素D增加了COPD发病率和死亡率的风险:一个基于大量人口的前性队列研究
Ying Zhu1,2, Shengjie Zhao3, Chen Zhu4
1Senior Department of Pulmonary and Critical Care Medicine, the Eighth Medical Center of Chinese PLA General Hospital, Beijing, China.
Chronic obstructive pulmonary diseases (Miami, Fla.)
|January 12, 2026
概括
较低的维生素D水平 (25~OH) D缺乏) 与患慢性阻塞性肺病 (COPD) 的风险更高,生存率更低有关. 这突出了维生素D.
科学领域:
- 肺部医学 肺部医学
- 内分泌学 在内分泌学.
- 营养科学 营养科学
背景情况:
- 维生素D (25(OH) D水平与慢性阻塞性肺病 (COPD) 之间的关系需要进一步澄清.
- 现有研究尚未确定维生素D的低水平是否会影响COPD的发展或预后.
研究的目的:
- 为了研究25~OH) D度与COPD发病率之间的关联.
- 为了检查25...OH) D水平和COPD生存率之间的关系.
主要方法:
- 利用来自328,855名参与者的英国生物库数据进行COPD患病率的横截面分析.
- 使用后勤回归来评估25...OH) D水平与COPD患病率之间的关联.
- 进行了对327,871个人的前性队列研究,使用Cox比例危险模型来评估事件COPD和生存结果,平均随访时间为15年.
主要成果:
- 患有25(OH) D缺乏症的人群中,COPD的患病率显著更高 (OR 1.266).
- 缺少OH) D与COPD发病率 (HR 1.874) 和死亡率 (HR 1.598) 的增加有关.
- 亚组分析表明,男性,目前的吸烟者,以及那些不服用维生素D补充剂的人,与抑郁症患者的死亡风险增加有更强的关联.
结论:
- 25 ,OH) D缺乏与COPD的发病率和存活率显著相关.
- 这些发现支持维生素D在COPD预防和治疗中的潜在作用.
- 进一步研究维生素D补充作为COPD预防策略是有必要的.
相关概念视频
COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
COPD: Management Using Bronchodilators and Corticosteroids
713
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
713


